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Obesity, hypertension, Type 2 diabetes mellitus (T2DM), and hypertriglyceri-
demia are risk factors for cardiovascular disease (CVD), and associations among
risk factors for CVD have been reported in many studies.
1-3 Obesity is a predictor
of impaired fasting glucose (IFG), pre-diabetic state, and hypertriglyceridemia.
4
Insulin resistance is increased by abdominal obesity, and fasting hyperinsulinemia
has been identified as a risk factor for the development of IFG.
5-7 It has also been
reported that the risk of IFG and T2DM increases with the severity of abdominal
obesity. Waist circumference (WC) was the measure of obesity more strongly
associated with the metabolic glucose disorders.
8 Prevention of IFG and
hypertriglyceridemia are closely linked to reduction in the body weight.
The prevalence of T2DM is growing rapidly, the prevalence of the IFG and
T2DM were 4.1%, 6.4% in Korea.
9 Framingham heart study reported that
impaired glucose tolerance (IGT) occurs frequently in obese people and that
obese people with IGT are at a high risk of developing T2DM.
6
Hypertriglyceridemia is known to be an independent risk factor for cereb-
rovascular accident (CVA).
10 The triglyceride (TG) tends to be related to obesity in
comparison with total cholesterol (TC).
11 Hypertriglyceridemia is caused by obesity,
smoking, drinking, T2DM, and chronic renal failure.
12 A 10% increase in weight
above ideal body weight was associated with increases in serum cholesterol and
fasting blood sugar (FBS) by factors of 12 mg/dL and 2 mg/dL, respectively.
13
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Purpose: This study sought to determine whether abdominal obesity is a risk factor for impaired fasting glucose
(IFG) and hypertriglyceridemia and to verify whether moderate effect of abdominal obesity on the relationship
between IFG and hypertriglyceridemia in Korea. Materials and Methods: Data from the Korean National Health
and Nutrition Examination Survey was used for the analysis. The study population included 5,938 subjects aged 20
year old drawn from non-diabetic participants in a health examination survey. The subjects were classified
according to the presence of abdominal obesity based on waist circumference, IFG based on their fasting blood
glucose level, and hypertriglyceridemia on their fasting triglyceride. Results: The multivariate-adjusted odds ratios
for the occurrence of hypertriglyceridemia were 2.91 in the abdominal obesity group as compared with the
nonobesity group and 1.31 in subjects with IFG compared with the normoglycemia controls. Abdominal obesity
was found to be positively moderated in the interaction between waist circumference and fasting blood sugar.
Conclusion: The moderate effect between abdominal obesity and IFG contributes to the development of
hypertriglyceridemia in Korea.
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INTRODUCTIONGerald studied the relationship between diabetes and
hypertriglyceridemia, and reported that hypertriglyceri-
demia could be caused by the level of very low-density
lipoprotein (VLDL) and a TG secretion increase due to
diabetes.
14 In addition, hypertriglyceridemia differs depend-
ing on the degree of glucose intolerance.
15 On the other
hand, hypertriglyceridemia is an independent risk factor
for the development of IFG and T2DM, which was dif-
ferent from Western studies.
1
Abdominal obesity is a risk factor of IFG and hypertri-
glyceridemia. But the causal relationships between IFG
and hypertriglyceridemia are not yet clear. Therefore, the
present study was performed to determine the relationships
between IFG and hypertriglyceridemia in subjects without
T2DM and to examine whether there are moderate effects
between changes in abdominal obesity according to IFG
and hypertriglyceridemia.
Research subjects
This study was based on the 2001 Korean National Health
and Nutrition Examination Survey (KNHANES II). Com-
plete data was obtained for 9,770 of 12,647 individuals
who participated in the survey. Subjects who had T2DM,
had taken medications for T2DM, or had FBS of ≥ 126
mg/dL were excluded. Consequently, 5,938 adults aged 20
years or older were selected for the study.
The KNHANES II is a national survey conducted jointly
by the Korea Institute for Health and Social Affairs and the
Korea Health Industry Development Institute, and is
commissioned by the Ministry of Health and Welfare in
accordance with the regulations in the National Health
Promotion Act. Selection methods for a nationwide rep-
resentative sample of Koreans and other survey methods
are detailed elsewhere.
16,17 The data used in this study was
originally provided by the Korea Institute for Health and
Social Affairs and the Korea Health Industry Development
Institute, and was analyzed again with their permission.
Measurements
WC was used as a measurement of abdominal obesity. The
diagnostic criteria of abdominal obesity is mostly provided
for Europeans and North Americans, and the criteria
differs depending on race, sex, and age. With reference to
the World Health Organization (WHO) Asia-Pacific Obe-
sity Criteria, the normal WC of Asian men was set at < 90
cm and that of women was set at < 80 cm; WC values above
this cutoff were classified as abdominal obesity.
18
In the case of FBS criteria, the WHO lowered the criteria
to 126 mg/dL in accordance with new diagnostic criteria of
the American Diabetes Association (ADA) in 1999. FBS
levels of 110-125 mg/dL are classified as IFG. The ADA
recommended that the diagnostic criteria of IFG should be
lowered from 110 mg/dL to 100 mg/dL in 2003.
19 With re-
ference to the above levels, FBS values below 100 mg/dL
were subsequently classified as normoglycemia, while
FBS values of 100-125 mg/dL and above were classified
as IFG in this study. 
In the case of TG classification, levels below 150 mg/dL
and 150 mg/dL and above were defined as normotrigly-
ceridemic and hypertriglyceridemia, respectively, based on
the National Cholesterol Education Program Adult
Treatment Panel III (NCEP-ATP III).
20
In the evaluation of education level, high school gradua-
tion and above was set as the 13th grade, and the education
level was classified as either below 13th grade or 13th
grade and above. The income level was classified according
to the monthly income on the basis of Korean currency
(1,000 Won = US$ 1.08).
Health examination survey
WC, FBS, and TG were measured during the KNHANES.
WC was measured to the nearest 0.1 cm at the narrowest
point between the lowest rib and the uppermost lateral
border of the right iliac crest. Blood samples were collected
from the antecubital vein to measure serum concentrations
of TG and glucose after a fast of 10-12 hours. 
Statistical analysis
Statistical analyses were performed using Statistical Pack-
age for the Social Sciences (SPSS) version 15.0 (SPSS
Inc., Chicago, IL, USA) for Windows. Chi-square analyses
were used to compare categorical variables. Multiple logist-
ic regression models were constructed for modeling in-
teraction between FBS, WC, and TG. A value of p < 0.05
(two-sided) was taken to indicate statistical significance.
Features of the population
The study population included more females (3,394, 57.2%)
than males (2,544, 42.8%). Nonobese subjects comprised
77.4% of the study population, while 22.7% of the subjects
had abdominal obesity based on WC. Normoglycemia
levels were seen in 68.7% of the participants, and IFG was
found in 31.3% on the basis of FBS. Normotriglyceridemic
was seen in 67.0% of the participants, and hypertrigly-
ceridemia was seen in 33.0% on the basis of TG (Table 1).
Analysis of the relationships between WC, FBS, and TG
As shown in Table 2, on the basis of WC, the relationship
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MATERIALS AND METHODS
RESULTSbetween FBS and TG was examined by classifying the
subjects into two groups: nonobesity and abdominal obesity.
Compared to subjects with normal FBS levels, nonobese
subjects with IFG had a statistically significant higher rate
of hypertriglyceridemia (p < 0.001). Additionally, com-
pared to subjects with normal FBS levels, abdominal
obesity subjects with IFG had a slightly higher rate of
hypertriglyceridemia, but the difference was not statisti-
cally significant .
As shown in Table 3, the relationship between WC and
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Table 1.Characteristics of the Study Subjects
Variable n %
Sex Male 2,544 42.8
Female 3,394 57.2
Age (yrs) 20 - 34 1,822 30.7
35 - 49 2,141 36.1
50 - 64 1,202 20.2
≥65 773 13.0
Education (yrs) < 13 1,713 28.9
≥13 4,217 71.1
Spouse No 1,534 25.8
Yes 4,403 74.2
Income (million / month) < 2 3,094 52.1
2 - 3.9 2,134 35.9
≥4 710 12.0
Smoke No 3,470 63.1
Yes 2,027 36.9
Drink No  1,687 30.7
Yes 3,810 69.3
Exercise No 3,945 71.8
Yes 1,546 28.2
Stress No 967 17.6
Yes 4,525 82.4
Waist circumference Non-obesity 4,593 77.4
Abdominal Obesity 1,345 22.7
Fasting blood sugar Normoglycemic 4,078 68.7
Impaired fasting glycemiac 1,860 31.3
Triglyceride Normotriglyceridemia 3,981 67.0
Hypertriglyceridemia 1,957 33.0
Table 2.The Difference between FBS and TG by WC
NO AO
Total
NTG HTG NGT HTG
Normoglycemia
2,215 (75.6) 717 (24.4) 623 (54.4) 523 (45.6) 4,078 (100.0)
(75.4) (67.8) (59.7) (58.1) (68.7)
IFG
722 (68.0) 340 (32.0) 421 (52.8) 377 (47.2) 1,860 (100.0)
(24.6) (32.2) (40.3) (41.9) (31.3)
Total
2,937 (73.5) 1,057 (26.5) 1,044 (53.7)  900 (46.3)  5,938 (100.0)
(100.0) (100.0) (100.0) (100.0) (100.0)
pvalue < 0.01 0.485
WC, waist circumference; FBS, fasting blood sugar; TG, triglyceride; IFG, impaired fasting glucose; NTG, normotriglyceridemic; HTG,  
hypertriglyceridemia;  NO, non-obesity; AO, abdominal obesity.
Values were expressed as n (%).TG was examined on the basis of FBS by classifying the
subjects into two groups: normoglycemia and IFG. In
subjects with IFG, the rate of hypertriglyceridemia was
higher in those with abdominal obesity as compared with
the nonobese subjects. The result in the normoglycemia
group was similar to that of the IFG group. These trends
were statistically significant (p< 0.0001).
As shown in Table 4, the relationship between WC and
FBS was examined on the basis of TG by classifying the
subjects into two groups: normotriglyceridemic and hyper-
triglyceridemia. In the hypertriglyceridemia group, the
incidence of IFG was high in subjects with abdominal
obesity as compared with the nonobese subjects. This
difference was statistically significant (p < 0.0001). The
result in the normotriglyceridemic group was similar to
that in the hypertriglyceridemia group.
Moderate effect among WC, FBS and TG
Multiple logistic regression with hypertriglyceridemia
indicated that the dependent variables, WC and FBS, were
significantly related. We examined whether there was a
moderator effect by interaction between WC and FBS that
had an effect on hypertriglyceridemia. The relationship is
described in Fig. 1, and the result was statistically signi-
ficant (p< 0.05) (Table 5). 
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Table 3.The Difference between TG and WC by FBS
Normoglycemia IFG
Total
NTG HTG NTG HTG
NO
2,215 (75.6) 717 (24.4) 722 (68.0) 340 (32.0) 3,994 (100.0)
(78.0) (57.8) (63.2) (47.4) (67.3)
AO
623 (54.4) 523 (45.6) 421 (52.8) 377 (47.2) 1,944 (100.0)
(22.0) (42.2) (36.8) (52.6) (32.7)
Total
2,838 (69.6) 1,240 (30.4) 1,143 (61.5) 717 (38.5) 5,938 (100.0)
(100.0) (100.0) (100.0) (100.0) (100.0)
pvalue < 0.01 < 0.01
WC, waist circumference; FBS, fasting blood sugar; TG, triglyceride; IFG, impaired fasting glucose; NTG, normotriglyceridemic; HTG,  
hypertriglyceridemia; NO, non-obesity; AO, abdominal obesity.
Values were expressed as n (%).
Table 4.The Difference between FBS and WC by TG
NTG HTG
Total
Normoglycemia IFG Normoglycemia IFG
NO
2,215 (75.4) 722 (24.6) 717 (67.8) 340 (32.2) 3,994 (100.0)
(78.0) (63.2) (57.8) (47.4) (67.3)
AO
623 (59.7) 421 (41.3) 523 (58.1) 377 (41.9) 1,944 (100.0)
(22.0) (36.8) (42.2) (52.6) (32.7)
Total
2,838 (71.3) 1,143 (28.7) 1,240 (63.4) 717 (36.6) 5,938 (100.0)
(100.0) (100.0) (100.0) (100.0) (100.0)
pvalue < 0.01 < 0.01
WC, waist circumference; FBS, fasting blood sugar; TG, triglyceride; IFG, impaired fasting glucose; NTG, normotriglyceridemic; HTG,  
hypertriglyceridemia; NO, non-obesity; AO, abdominal obesity.
Values were expressed as n (%).
Fig. 1. The interaction effect between FBS and WC on TG. WC, waist
circumference; FBS, fasting blood sugar; TG, triglyceride; IFG, impaired fasting
glucose.Various indices can be used to indicate abdominal obesity,
and WC has been suggested to reflect visceral obesity better
than the waist-to-hip ratio.
21 Pouliot, et al.
22 suggested that
WC is a useful index for the measurement of abdominal fat.
Freedman, et al.
23 showed that WC has the highest correla-
tion to TG, HDL-C/TC, and systolic blood pressure as
compared with other variables for measuring the body, and
that it is a risk factor for coronary artery disease (CAD).
WC was also suggested as a criterion of abdominal
obesity in NCEP-ATP III. In the case of Western subjects,
abdominal obesity is defined as WC of 102 cm and above
in men and 88 cm and above in women. According to the
recommendations of the WHO Asia-Pacific Region,
abdominal obesity in Asians is best defined as a WC of 90
cm or above in men and 80 cm or above in women.
11 The
cutoff point for the criteria of abdominal obesity differs
depending on age, sex, and race. In Korea, abdominal
obesity is defined as  a WC of 90 cm or above in men and
85 cm or above in women.
24 We used the criteria of WHO
Asia-Pacific Region for comparison with other countries,
the prevalence of abdominal obesity is 22.7% on WC.
WC was a risk factor more strongly associated with the
increased levels of IFG and IGT.
25,26 Guerrero-Romero, et
al.
8 reported that the probability of IFG, IGT, and IFG +
IGT in obesity were 3.1, 3.2, and 2.8 times higher than in
non-obesity, respectively. In this study, abdominal obesity
was significantly related to IFG, regardless of hypertrigly-
ceridemia. The odds ratio of having IFG was 2.01 (95%
CI: 1.703-2.362, p < 0.05) higher in people with abdominal
obesity than in nonobese individuals. The relationship bet-
ween obesity and diabetes has been examined extensively.
IFG is a prediabetic state, and this study clearly demonstrated
a relationship between abdominal obesity and glucose
metabolism.
The increase of TG in obese patients is due to an increase
in VLDL production in the liver and an increase in TG
secretion into the blood due to insulin resistance and
hyperinsulinemia. The TG rise is caused by increased TG
resolution by free fatty acid (FFA), the concentrations of
which are high in obese patients.
27 Wolf and Grundy
28
reported that obese people who lost weight experienced
reductions in their TG levels of about 40%.
In the present study, a statistically significant relation-
ship was also seen between abdominal obesity and hyper-
triglyceridemia regardless of IFG. The odds ratio of hypertri-
glyceridemia was 2.9 times higher in people with abdominal
obesity (95% CI: 2.473-3.426, p < 0.05) than in nonobese
subjects. This finding was similar to the results reported
previously.
27,28
Gerald reported that hypertriglyceridemia is caused by
the secretion increase of VLDL and TG due to diabetes.
13
The PROCAM study indicated that hypertriglyceridemia
and diabetes are independent risk factors for the incidence
of CVA.
29
Salomaa, et al.
15 compared the degree of hypertriglyceri-
demia according to the degree of glucose intolerance in Fin-
nish subjects aged 45 to 64 years old. In the case of men,
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DISCUSSION
Table 5. Odds Ratio of the Multiple Logistic Regression for the Hypertriglyceridemia  (ORs and 95% CI) 
Variable name Measurements OR 95% CI
Sex Male (0 = female) 2.596* 2.153 - 3.130
Age1 35 - 49 (0 = 20 - 34) 1.394* 1.178 - 1.650
Age2 50 - 64 (0 = 20 - 34) 1.936* 1.597 - 2.346
Age3 65 ≤(0 = 20 - 34) 1.956* 1.570 - 2.438
Education 13 ≤(0 = < 13) 1.071 0.918 - 1.248
Spouse Yes (0 = no) 1.046 0.899 - 1.218
Income1 2 - 3.9 (0 = < 2) 0.980 0.855 - 1.123
Income2 4 ≤(0 = < 2) 0.946 0.773 - 1.159
Smoke Yes (0 = no) 1.123 0.938 - 1.346
Drink Yes (0 = no) 1.068 0.926 - 1.232
Exercise No (0 = yes) 1.091 0.953 - 1.248
Stress Yes (0 = no) 0.972 0.829 - 1.140
WC AO (0 = Non-obesity) 2.911* 2.473 - 3.426
FBS IFG (0 = Normoglucose) 1.310* 1.109 - 1.546
WC FBS 0.765* 0.592 - 0.989
WC, waist circumference; AO, abdominal obesity; FBS, fasting blood sugar; IFG, impaired fasting glucose; OR, odds ratio; CI, 
confidence Interval.
*p< 0.05.hypertriglyceridemia occurred in 47.6% of patients with
diabetes, 21.9% with IGT, and 15.4% with normal glucose
tolerance (NGT). In the case of women, hypertriglyceri-
demia occurred in 51.9% of patients with diabetes, 25.7%
with IGT, and 10.7% with NGT. These differences were
statistically significant after adjusting for age and BMI.
On the other hand, a 9-year longitudinal study perfor-
med by Kametani, et al.
1 in Japan indicated that hypertri-
glyceridemia and obesity are independent risk factors for
the development of diabetes mellitus. The multivariate-
adjusted relative risks for the development of IFG were
1.38 for hypertriglyceridemia and 1.30 for obesity. The
relative risk for the development of diabetes mellitus was
1.003 for the TG level.
1
St-Pierre, et al.
2 reported that IFG did not have an effect
on the production of CAD in cases of nonobesity and
normotriglyceridemic, but an effect was observed on the
incidence of CAD in cases of abdominal obesity and
hypertriglyceridemia when IFG was higher.
After controlling for age and abdominal obesity in this
study, the odds ratio for hypertriglyceridemia in people with
IFG was 1.31 (95% CI: 1.109-1.546, p < 0.05) times higher
than in people with a normal glucose level. The results of
the present study were also similar to other studies.
1,15
Obesity was significantly associated with high serum
triglycerides in all glucose tolerance groups.
15 Subjects in the
present study were classified into nonobesity and abdominal
obesity groups. The relationship between IFG and hypertri-
glyceridemia was examined. IFG and hypertriglyceridemia
were significantly related in nonobese individuals, as shown
in Table 2, but there was no such relationship in abdominal
obesity, indicating that there may be an interaction among
WC, FBS, and TG. This was supported by the observation
that WC and FBS were significantly associated with the
dependent variable of hypertriglyceridemia.
This study has limitations. Because of the cross-sectional
nature of the study, our study does not identify a causal
relationship. Nevertheless, this study is important to deter-
mine the relationships and examine the interactions among
abdominal obesity, IFG, and hypertriglyceridemia.
This study was supported by a grant of the Korean Health
21 R&D Project, Ministry of Health and Welfare, Republic
of Korea(A050463).
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